Atlas Trials

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Clinical trial NCT00499590 · TERMINATED

Trial details

NCT number
NCT00499590
Sponsor
OPKO Health, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2007-08-01
Primary completion
2009-03-01
Enrollment
338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.